Veterinary Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Veterinary drugs are termed as medications used to treat various medical conditions in animals. Veterinary drugs include anti-infective drugs, anti-inflammatory drugs, and parasiticides, which are administered orally in animals. Veterinary drugs are used in various animals, including companion animals such as dogs and cats and livestock animals such as cattle, pigs, and poultry. Moreover, the medicine is administered in animals via various routes such as oral route, parenteral route, and some parasiticidal drug preparations are administered through topical route.
MARKET DYNAMICS
The veterinary drugs market has shown a significant evolution over the forecast period. The rise of the veterinary drugs market is driven by the increase in the number of pet owners and the surge in livestock population worldwide. According to American Pet Products Association (APPA), 67% percent of United States households own a pet, and estimated that 78 million dogs and 85.8 million cats are owned in the United States. Furthermore, factors such as a surge in prevalence of various medical conditions in animals and a rise in demand for livestock products also boost the veterinary medicine market growth. Also, the rise in animal healthcare expenditure is another major factor that fuels the market's development. However, lack of veterinary infrastructure facilities in underdeveloped nations and stringent regulations associated with medicated feed additives restrict veterinary medicine market growth. Conversely, an increase in awareness toward animal health offers a lucrative opportunity for the veterinary medicine market.
MARKET SCOPE
The "Veterinary Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, focusing on the global market trend analysis. This report outlines the veterinary drugs market with detailed market segmentation by product, route of administration, and end-user. The veterinary drugs market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on leading players' market status in the veterinary drugs market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, route of administration, and end user. Based on the product, the market is segmented as anti-infective drugs, anti-inflammatory drugs, parasiticides, and others. Based on the route of administration, the segmentation of the market is into oral route, parenteral route, and topical route. Based on end user, the segmentation of the market is into veterinary hospitals, veterinary clinics, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the veterinary drugs market based on various segments. The report also consists of market size and forecast estimates from the year 2021 to2031with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The veterinary drugs market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the veterinary drugs market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Veterinary drugs market in these regions.
By Product
By Route of Administration
By End User
MARKET PLAYERS
The report contains critical developments in the veterinary drugs market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the veterinary drugs market are estimated to have profitable growth opportunities in the coming years with the higher demand for veterinary drugs in the global market. Given below is the list of a few companies engaged in the veterinary drugs market.
The report also offers key players' profiles in the veterinary drugs market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.
Veterinary drugs are termed as medications used to treat various medical conditions in animals. Veterinary drugs include anti-infective drugs, anti-inflammatory drugs, and parasiticides, which are administered orally in animals. Veterinary drugs are used in various animals, including companion animals such as dogs and cats and livestock animals such as cattle, pigs, and poultry. Moreover, the medicine is administered in animals via various routes such as oral route, parenteral route, and some parasiticidal drug preparations are administered through topical route.
MARKET DYNAMICS
The veterinary drugs market has shown a significant evolution over the forecast period. The rise of the veterinary drugs market is driven by the increase in the number of pet owners and the surge in livestock population worldwide. According to American Pet Products Association (APPA), 67% percent of United States households own a pet, and estimated that 78 million dogs and 85.8 million cats are owned in the United States. Furthermore, factors such as a surge in prevalence of various medical conditions in animals and a rise in demand for livestock products also boost the veterinary medicine market growth. Also, the rise in animal healthcare expenditure is another major factor that fuels the market's development. However, lack of veterinary infrastructure facilities in underdeveloped nations and stringent regulations associated with medicated feed additives restrict veterinary medicine market growth. Conversely, an increase in awareness toward animal health offers a lucrative opportunity for the veterinary medicine market.
MARKET SCOPE
The "Veterinary Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, focusing on the global market trend analysis. This report outlines the veterinary drugs market with detailed market segmentation by product, route of administration, and end-user. The veterinary drugs market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on leading players' market status in the veterinary drugs market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, route of administration, and end user. Based on the product, the market is segmented as anti-infective drugs, anti-inflammatory drugs, parasiticides, and others. Based on the route of administration, the segmentation of the market is into oral route, parenteral route, and topical route. Based on end user, the segmentation of the market is into veterinary hospitals, veterinary clinics, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the veterinary drugs market based on various segments. The report also consists of market size and forecast estimates from the year 2021 to2031with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The veterinary drugs market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the veterinary drugs market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Veterinary drugs market in these regions.
Veterinary Drugs Market Report Analysis
Veterinary Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Zoetis
- Boehringer Ingelheim International GmbH
- Bayer AG
- Eli Lilly and Company
- Ceva
- Dechra Pharmaceuticals PLC
- Intervet Inc Merck Co Inc
- Virbac
- Vetoquinol S A
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product
- Anti-Infective Drugs
- Anti-Inflammatory Drugs
- Parasiticides
By Route of Administration
- Oral Route
- Parenteral Route
- Topical Route
By End User
- Veterinary Hospitals
- Veterinary Clinics
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report contains critical developments in the veterinary drugs market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the veterinary drugs market are estimated to have profitable growth opportunities in the coming years with the higher demand for veterinary drugs in the global market. Given below is the list of a few companies engaged in the veterinary drugs market.
The report also offers key players' profiles in the veterinary drugs market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Zoetis
- Boehringer Ingelheim International GmbH
- Bayer AG
- Eli Lilly and Company.
- Ceva
- Dechra Pharmaceuticals PLC.
- Intervet Inc. (Merck & Co. Inc.)
- Virbac.
- Vetoquinol S.A.
- Evonik Industries AG.
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.
Veterinary Drugs Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1.Zoetis
2.Boehringer Ingelheim International GmbH
3.Bayer AG
4.Eli Lilly and Company.
5.Ceva
6.Dechra Pharmaceuticals PLC.
7.Intervet Inc. (Merck & Co. Inc.)
8.Virbac.
9.Vetoquinol S.A.
10.Evonik Industries AG.
1.Zoetis
2.Boehringer Ingelheim International GmbH
3.Bayer AG
4.Eli Lilly and Company.
5.Ceva
6.Dechra Pharmaceuticals PLC.
7.Intervet Inc. (Merck & Co. Inc.)
8.Virbac.
9.Vetoquinol S.A.
10.Evonik Industries AG.
Get Free Sample For